Total planned funding: $170,284,709
Allocations
Countries/Regions
Ukraine | $170,284,709 |
Organizational Types
Unknown | $47,076,473 |
NGO | $38,272,963 |
Private Contractor | $32,642,104 |
Own Agency | $21,129,317 |
Multi-lateral Agency | $11,625,607 |
University | $10,166,234 |
Implementing Agency | $5,200,000 |
Other USG Agency | $3,922,011 |
Host Country Government Agency | $250,000 |
Program Areas
Governance and Systems | $67,209,920 |
Treatment | $35,967,730 |
Testing | $28,254,678 |
Prevention | $13,983,598 |
Management and Operations | $13,459,016 |
Care | $11,409,767 |
Budget Codes
OHSS: Health Systems Strengthening | $33,475,004 |
HVCT: Testing: HIV Testing and Counseling | $28,254,678 |
HTXS: Treatment: Adult Treatment | $24,403,735 |
HVSI: Strategic Information | $21,077,748 |
HVMS: Management and Operations | $13,459,016 |
HLAB: Laboratory Infrastructure | $12,657,168 |
HTXD: Treatment: ARV Drugs | $11,563,995 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $6,654,795 |
HVTB: Care: TB/HIV | $5,755,112 |
HVOP: Sexual Prevention: Other Sexual Prevention | $5,500,678 |
HBHC: Care: Adult Care and Support | $3,725,462 |
HKID: Care: Orphans and Vulnerable Children | $1,929,193 |
HMBL: Biomedical Prevention: Blood Safety | $1,137,874 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HMIN: Biomedical Prevention: Injection Safety | $250,000 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $146,894 |
PDTX: Treatment: Pediatric Treatment | $0 |
PDCS: Care: Pediatric Care and Support | $0 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $0 |
Top Partner Programs
Not Available:
$34,921,614
Countries/Regions
Chemonics International:
$19,672,383
Countries/Regions
USG Aggregated Agencies:
$18,453,667
Countries/Regions
Deloitte Consulting Limited:
$10,671,511
Countries/Regions